A review of life science current events reported by MedCity News this week:
6 emerging health IT companies you should know (but probably don’t). The number of mobile app and health IT companies are growing almost as fast as the market itself. So here’s a half-dozen early-stage companies you should already know about (but probably don’t). Some are addressing game-changing problems. Others come with top-tier management teams. And almost universally they have major market opportunities.
Audit report: Why CEO Chris Stern was ousted from Oxygen Biotherapeutics. An audit investigation into former Oxygen Biotherapeutics (NASDAQ:OXBT) CEO Chris Stern concluded that Stern lied about his academic background and engaged in undisclosed securities deals with a vendor that he later tried to cover up.
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Medical device processor SterilMed acquired by Ethicon Endo-Surgery. Surgical products company Ethicon Endo-Surgery, a division of Johnson & Johnson (NYSE:JNJ), is entering the medical device reprocessing and remanufacturing business with a planned acquisition of SterilMed.
Why startup medical device companies should enjoy patent reform. Getting prioritized examination, which shortens the regulatory approval process to one year with a limit of 10,000 patent applications, could be an asset to small medical device companies seeking funding, said Mary Merchant, the head of the biotechnology team in Ballard Spahr’s patent group and a member of the group’s chemical, pharmaceutical, and medical device technology teams in Philadelphia.
After the medical device tax apocalypse: (Contract) workers survive. But even if every doomsday scenario is true, there will be life after 2013 – the first year of the medical device tax. For many medical device workers, though, their futures will be in contract work as opposed to full-time jobs, predicts Paula Norbom, president of Minneapolis-based staffing company Talencio, which places contract professionals within the medtech and biotech industries.